These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27890661)

  • 21. Optogenetic and Chemogenetic Approaches for Studying Astrocytes and Gliotransmitters.
    Bang J; Kim HY; Lee H
    Exp Neurobiol; 2016 Oct; 25(5):205-221. PubMed ID: 27790055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.
    Weston M; Kaserer T; Wu A; Mouravlev A; Carpenter JC; Snowball A; Knauss S; von Schimmelmann M; During MJ; Lignani G; Schorge S; Young D; Kullmann DM; Lieb A
    Sci Adv; 2019 Apr; 5(4):eaaw1567. PubMed ID: 31001591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the reward system boosts innate and adaptive immunity.
    Ben-Shaanan TL; Azulay-Debby H; Dubovik T; Starosvetsky E; Korin B; Schiller M; Green NL; Admon Y; Hakim F; Shen-Orr SS; Rolls A
    Nat Med; 2016 Aug; 22(8):940-4. PubMed ID: 27376577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Optogenetic and Chemogenetic Control of Neurons.
    Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
    Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease.
    Vazey EM; Aston-Jones G
    Brain Res; 2013 May; 1511():153-63. PubMed ID: 23337619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action.
    Ozawa A; Arakawa H
    Behav Brain Res; 2021 May; 406():113234. PubMed ID: 33741409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DREADDs in Drosophila: a pharmacogenetic approach for controlling behavior, neuronal signaling, and physiology in the fly.
    Becnel J; Johnson O; Majeed ZR; Tran V; Yu B; Roth BL; Cooper RL; Kerut EK; Nichols CD
    Cell Rep; 2013 Sep; 4(5):1049-59. PubMed ID: 24012754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acoustically targeted chemogenetics for the non-invasive control of neural circuits.
    Szablowski JO; Lee-Gosselin A; Lue B; Malounda D; Shapiro MG
    Nat Biomed Eng; 2018 Jul; 2(7):475-484. PubMed ID: 30948828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemogenetics-A Transformational and Translational Platform.
    English JG; Roth BL
    JAMA Neurol; 2015 Nov; 72(11):1361-6. PubMed ID: 26409113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemogenetic tools to interrogate brain functions.
    Sternson SM; Roth BL
    Annu Rev Neurosci; 2014; 37():387-407. PubMed ID: 25002280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bidirectional communication between neural and immune systems].
    Hori T
    Nihon Rinsho; 1994 Nov; 52(11):2843-9. PubMed ID: 7996678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.
    Elenkov IJ; Wilder RL; Chrousos GP; Vizi ES
    Pharmacol Rev; 2000 Dec; 52(4):595-638. PubMed ID: 11121511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Controlling sleep/wakefulness using optogenetics].
    Yamanaka A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2015 Aug; 35(4):97-102. PubMed ID: 26434098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optogenetics in primates: a shining future?
    Gerits A; Vanduffel W
    Trends Genet; 2013 Jul; 29(7):403-11. PubMed ID: 23623742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DREADDs for Neuroscientists.
    Roth BL
    Neuron; 2016 Feb; 89(4):683-94. PubMed ID: 26889809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Pioneers of Optogenetics in Neuroscience.
    Somuncu ÖS; Berns HM; Sanchez JG
    Adv Exp Med Biol; 2020; 1288():47-60. PubMed ID: 31983055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Powerful DREADD: Revealing Structural Drivers of Functional Dynamics.
    Khambhati AN; Bassett DS
    Neuron; 2016 Jul; 91(2):213-5. PubMed ID: 27477013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically encoded tools: bridging the gap between neuronal identity and function.
    Cho YK
    ACS Chem Neurosci; 2015 Jan; 6(1):14-5. PubMed ID: 25574970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.
    Urban DJ; Roth BL
    Annu Rev Pharmacol Toxicol; 2015; 55():399-417. PubMed ID: 25292433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using rAAV2-retro in rhesus macaques: Promise and caveats for circuit manipulation.
    Cushnie AK; El-Nahal HG; Bohlen MO; May PJ; Basso MA; Grimaldi P; Wang MZ; de Velasco Ezequiel MF; Sommer MA; Heilbronner SR
    J Neurosci Methods; 2020 Nov; 345():108859. PubMed ID: 32668316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.